Correction: An aniline-bridged bis (pyrazolyl)alkane ligand for dizinc-catalysed ring-opening polymerization
Dalton Transactions · 2026 · 55 (11) · 4747-4747
DOI: 10.1039/d6dt90040b ↗Kurz gefasst
Korrektur in der Zeitschrift Dalton Transactions, 2026. Verfasst von Pratyush K Naik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Houston, 4800 Calhoun Road, Houston, Texas 77004, USA. rjcomito@central.uh.edu. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Welch Foundation, Division of Chemistry, American Chemical Society Petroleum Research Fund.
Abstract (Originalsprache)
Correction for ‘An aniline-bridged bis (pyrazolyl)alkane ligand for dizinc-catalysed ring-opening polymerization’ by Pratyush K. Naik et al. , Dalton Trans. , 2024, 53 , 17443–17447, https://doi.org/10.1039/D4DT02837F.
Autor:innen und Institutionen
- Department of Chemistry, The University of Houston, 4800 Calhoun Road, Houston, Texas 77004, USA. rjcomito@central.uh.edu.
- Proteogenomics Research Institute for Systems Medicine, 505 Coast Blvd. South, La Jolla, CA 92037, USA.
Förderung
- Welch Foundation
- Division of Chemistry
- American Chemical Society Petroleum Research Fund
- University of Houston
Zitieren
APA
Naik, P. K., Gu, Z., & Comito, R. J. (2026). Correction: An aniline-bridged bis (pyrazolyl)alkane ligand for dizinc-catalysed ring-opening polymerization. Dalton Transactions, 55(11), 4747-4747. https://doi.org/10.1039/d6dt90040b
Vancouver
Naik PK, Gu Z, Comito RJ. Correction: An aniline-bridged bis (pyrazolyl)alkane ligand for dizinc-catalysed ring-opening polymerization. Dalton Transactions. 2026;55(11):4747-4747. doi:10.1039/d6dt90040b
BibTeX
@article{Naik2026,
author = {Naik, Pratyush K and Gu, Zipeng and Comito, Robert J},
title = {Correction: An aniline-bridged bis (pyrazolyl)alkane ligand for dizinc-catalysed ring-opening polymerization},
journal = {Dalton Transactions},
year = {2026},
volume = {55},
number = {11},
pages = {4747--4747},
doi = {10.1039/d6dt90040b}
}
EUVIMED